No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GILD Gilead Sciences
- 66.160
- -0.770-1.15%
Close Apr 18 16:00 ET
- 66.260
- +0.100+0.15%
Post 16:06 ET
82.50BMarket Cap14.70P/E (TTM)
67.020High65.900Low6.39MVolume67.010Open66.930Pre Close423.40MTurnover0.51%Turnover Ratio14.70P/E (Static)1.25BShares86.97452wk High3.61P/B82.33BFloat Cap65.90052wk Low3.00Dividend TTM1.24BShs Float91.089Historical High4.53%Div YieldTTM1.67%Amplitude0.414Historical Low66.242Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Gilead Sciences Publishes 2023 ESG Impact Report
NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report, which uses the ESG framework to highlight the successes and
What the Options Market Tells Us About Gilead Sciences
Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences (NASDAQ:GILD), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga un
Stifel Starts Mirum at Buy, Cites IBATi Drug Potential
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
Gilead Sciences Price Target Cut to $75.00/Share From $81.00 by UBS
Gilead Sciences Price Target Cut to $75.00/Share From $81.00 by UBS
Gilead Sciences Is Maintained at Neutral by UBS
Gilead Sciences Is Maintained at Neutral by UBS
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
